Harpoon Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for HARP

Based on 2 analysts offering 12 month price targets for Harpoon Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell HARP stock?

Based on 3 analysts offering ratings for Harpoon Therapeutics Inc.
Strong Buy
0 analysts 0%
1 analysts 33.33%
2 analysts 66.67%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HARP stock forecasts and price targets.

HARP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Truist Securities
Bottom 10%
Bottom 16%
SVB Leerink
Bottom 2%

1 of 1

HARP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EQ$0.71$7.00+891.50%Strong Buy
NLSP$1.36$4.00+194.12%Strong Buy
CASI$1.82$10.00+449.45%Strong Buy

Harpoon Therapeutics Stock Forecast FAQ

Is Harpoon Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: HARP) stock is to Hold HARP stock.

Out of 3 analysts, 0 (0%) are recommending HARP as a Strong Buy, 1 (33.33%) are recommending HARP as a Buy, 2 (66.67%) are recommending HARP as a Hold, 0 (0%) are recommending HARP as a Sell, and 0 (0%) are recommending HARP as a Strong Sell.

If you're new to stock investing, here's how to buy Harpoon Therapeutics stock.

What is HARP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HARP price target, the average HARP price target is $3.00, with the highest HARP stock price forecast at $4.00 and the lowest HARP stock price forecast at $2.00.

On average, Wall Street analysts predict that Harpoon Therapeutics's share price could reach $3.00 by Dec 14, 2023. The average Harpoon Therapeutics stock price prediction forecasts a potential upside of 359.42% from the current HARP share price of $0.65.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.